The function and mechanism of COX-2 in angiogenesis of gastric cancer cells
2011

COX-2's Role in Gastric Cancer Angiogenesis

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Liping Yao, Fei Liu, Hong Liu, Li Sun, Shuhui Liang, Kaichun Wu, Daiming Fan

Primary Institution: State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Fourth Military Medical University

Hypothesis

The study aimed to investigate the effect of COX-2 siRNA on proliferation and angiogenesis of gastric cancer cells.

Conclusion

COX-2 might mediate tumor angiogenesis and growth, and could be considered as a target for gastric cancer therapy.

Supporting Evidence

  • Down-regulation of COX-2 significantly inhibited the growth of gastric cancer cells in vitro and in vivo.
  • 23 angiogenesis-related molecules were found to be involved in COX-2-induced angiogenesis suppression.
  • COX-2 down-regulation suppressed the migration and tube formation of human umbilical vein endothelial cells.

Takeaway

This study found that reducing COX-2 in gastric cancer cells can slow down their growth and stop blood vessel formation, which is important for tumors to grow.

Methodology

The gastric cancer cell line SGC7901 was transfected with COX-2 siRNA, and growth and angiogenesis were assessed using in vitro and in vivo assays.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-9966-30-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication